Want to play again? or you missed our webinar to find out more about our oustanding bioactive for glucose intolerance. Wednesday, May 20 – 11 am (ET) WEBCAST HERE: https://event.webcasts.com/starthere.jsp?ei=1300789&tp_key=eff89beed9

Due to Covid-19, CPHI North America is postponed to 2021! It will be the opportunity to showcase innovative products and services to the North American pharmaceutical supply chain. Ingredia will present its natural dairy bioactives dedicated to health: Pep2Dia® an innovative bioactive to manage blood sugar and Lactium® for stress management. Meet us at booth #2005! Contact us with any … Read More

Pep2Dia® is the result of extensive research and collaboration between Ingredia’s scientists and LIENSs-CNRS La Rochelle University in France. Pep2Dia® has proven efficacy on glycaemia after meals. Pre-clinical and clinical studies support Pep2Dia®’s action to reduce postprandial glycaemia with a significative effect versus the placebo. Learn More Here